British researchers have discovered long-term low dosage aspirin consumption appears to be successful in reducing the risk of many types of cancer. In their study reviewing more than 25,000 individuals from previous trials, cancer deaths during the trials were 21 percent lower and 25 percent lower after 5 years post trial in those taking low dosages of aspirin. The most significant cancer reduction for those taking low dose aspirin was that of gastrointestinal cancer where death rates were 54 percent lower after 5 years. Findings indicated the cancer benefits increased with duration of aspirin consumption. Although aspirin consumption has an associated risk of stomach bleeding, given these new findings researchers suggest healthy people could consume 75 mg of aspirin daily from the age of 40 to 45 through to 70 to 75 years of age. After 70 to 75, the increase risk of bleeding may become too great.